Evidence map›Paper›PMID 41973598›Full record

ArticleThe MAK collection for occupational health and safety2025

Mycotoxins - Determination of aflatoxins, ochratoxin A, free ochratoxin α, gliotoxin, citrinin, and dihydrocitrinone in urine by LC-MS/MS: Biomonitoring Method - Translation of the German version from 2025.

Marion Berger, Max Deharde, Judith Neuhoff, Bernhard Monien, Solveigh Siodlaczek, Thomas Göen, Andrea Hartwig, MAK Commission

Abstract read
In one paragraph

Article in The MAK collection for occupational health and safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marion BergerFederal Institute for Occupational Safety and Health (BAuA). Division 4 - Hazardous Substances and Biological Agents. Unit 4.2 - Health Surveillance. Biological Monitoring Nöldnerstraße 40/42 10317 Berlin Germany.
Max DehardeFederal Institute for Occupational Safety and Health (BAuA). Division 4 - Hazardous Substances and Biological Agents. Unit 4.2 - Health Surveillance. Biological Monitoring Nöldnerstraße 40/42 10317 Berlin Germany.
Judith NeuhoffFederal Institute for Occupational Safety and Health (BAuA). Division 4 - Hazardous Substances and Biological Agents. Unit 4.2 - Health Surveillance. Biological Monitoring Nöldnerstraße 40/42 10317 Berlin Germany.
Bernhard MonienGerman Federal Institute for Risk Assessment. Unit 54 - Food Safety Department Max-Dohrn-Straße 8-10 10589 Berlin Germany.
Solveigh SiodlaczekGerman Federal Institute for Risk Assessment. Unit 54 - Food Safety Department Max-Dohrn-Straße 8-10 10589 Berlin Germany.
Thomas GöenFriedrich-Alexander-Universität Erlangen-Nürnberg. Institute and Outpatient Clinic of Occupational, Social, and Environmental Medicine Henkestraße 9-11 91054 Erlangen Germany.
Andrea HartwigInstitute of Applied Biosciences. Department of Food Chemistry and Toxicology. Karlsruhe Institute of Technology (KIT) Adenauerring 20a, Building 50.41 76131 Karlsruhe Germany.
MAK Commission

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The working group "Analyses in Biological Materials" of the German Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission) developed and verified the presented biomonitoring method. The aim of this method is the selective and sensitive quantitation of aflatoxins (aflatoxins B1, B2, G1, G2, M1), ochratoxin A (OTA), free ochratoxin

Indexed as

aflatoxinsbiomonitoringcitriningliotoxinLC-MS/MSmould toxinmycotoxinsochratoxin Aurine

Identifiers

PMID41973598
PMCPMC12443195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.